TippingPoint Biosciences
Therapeutics company focused on drug discovery targeting the aberrant DNA in cancer cells.
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
* | N/A | Seed | |
Total Funding | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
* | N/A | Seed | |
Total Funding | - |